XTL Biopharmaceuticals Ltd. (XTLB) Financials

$1.14

$0.06 (-5%)
Last update: 04:00 PM EST
Day's range
$1.12
Day's range
$1.25
$3M$3M$2M$2M$1M$1M$0$0-$1M-$1M-$2M-$2MEarning20182018201920192020202020212021202220222023202320242024-226.5%-226.5%-227%-227%-227.5%-227.5%-228%-228%-228.5%-228.5%-229%-229%Profit Margin
Profit Margin
Revenue
Earnings

XTLB Income statement / Annual

Last year (2024), XTL Biopharmaceuticals Ltd.'s total revenue was $451,000.00, and the percentage change from the previous year is not available. In 2024, XTL Biopharmaceuticals Ltd.'s net income was -$1.03 M. See XTL Biopharmaceuticals Ltd.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $451,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $448,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit $3,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0.01 0 0 0 0 0 0 0 0 0
Research and Development Expenses $98,000.00 $31,000.00 $30,000.00 $30,000.00 $38,000.00 $35,000.00 $38,000.00 $43,000.00 $443,000.00 $578,000.00
General & Administrative Expenses $1.87 M $734,000.00 $850,000.00 $1.00 M $910,000.00 $807,000.00 $755,000.00 $1.19 M $1.26 M $1.41 M
Selling & Marketing Expenses $178,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $2.05 M $734,000.00 $850,000.00 $1.00 M $910,000.00 $807,000.00 $755,000.00 $1.19 M $1.26 M $1.41 M
Other Expenses $31,000.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $2.18 M $765,000.00 $880,000.00 $1.03 M $948,000.00 $842,000.00 $793,000.00 $1.25 M $1.71 M $2.00 M
Cost And Expenses $2.62 M $765,000.00 $880,000.00 $1.03 M $948,000.00 $842,000.00 $793,000.00 $1.25 M $1.71 M $2.00 M
Interest Income $34,000.00 $36.00 $36,000.00 $8,000.00 $33,000.00 $93,000.00 $87,000.00 $16,000.00 $0.00 $0.00
Interest Expense $28,000.00 $0.00 $0.00 $0.00 $0.00 $29,000.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $199,000.00 $1,000.00 $1,000.00 $1,000.00 $1,000.00 $842,000.00 $1,000.00 $1,000.00 $3,000.00 $7,000.00
EBITDA -$930,000.00 -$764,000.00 -$879,000.00 -$1.03 M -$947,000.00 $0.00 -$792,000.00 -$1.25 M -$1.71 M -$2.00 M
EBITDA Ratio -2.06 0 0 0 0 0 0 0 0 0
Operating Income Ratio -4.82 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net $1.02 M -$1.02 M -$468,000.00 $1.47 M -$2.01 M $79,000.00 $4.42 M $465,000.00 $16,000.00 -$11,000.00
Income Before Tax -$1.16 M -$1.78 M -$1.35 M $435,000.00 -$2.95 M -$1.35 M $2.99 M -$781,000.00 -$2.55 M -$3.62 M
Income Before Tax Ratio -2.57 0 0 0 0 0 0 0 0 0
Income Tax Expense -$130,000.00 $0.00 $468,000.00 -$1.47 M $0.00 -$69,000.00 -$80,000.00 -$457,000.00 $832,000.00 $2.31 M
Net Income -$1.03 M -$1,782.00 -$1.35 M $435,000.00 -$782,000.00 -$1.35 M $2.99 M -$781,000.00 -$2.55 M -$4.31 M
Net Income Ratio -2.28 0 0 0 0 0 0 0 0 0
EPS -0.15 0 -0.25 0.1 -0.15 -0.26 0.58 -0.17 -0.93 -1.63
EPS Diluted -0.15 0 -0.25 0.07 -0.15 -0.26 0.58 -0.17 -0.93 -1.63
Weighted Average Shares Out $6.73 M $5.45 M $5.45 M $5.32 M $5.14 M $5.14 M $5.14 M $4.70 M $2.74 M $2.64 M
Weighted Average Shares Out Diluted $7.04 M $5.45 M $5.45 M $6.16 M $5.14 M $5.14 M $5.14 M $4.70 M $2.74 M $2.64 M
Link